Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Colloids and Surfaces B: Biointerfaces

• Publication date

  2011-07-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.colsurfb.2011.02.038PMID 21435845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.

  2010cited by this paper
• Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers

  2009cited by this paper
• In vivo anti-tumor efficacy of docetaxel-loaded thermally responsive nanohydrogel

  2009cited by this paper
• Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review.

  2009cited by this paper
• The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma.

  2009cited by this paper
• Lipid nanoparticles for parenteral delivery of actives.

  2009cited by this paper
• Nanostructured lipid carrier-based hydrogel formulations for drug delivery: A comprehensive review

  2009cited by this paper
• Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel.

  2009cited by this paper
• Paclitaxel and docetaxel in the treatment of breast cancer.

  2008cited by this paper
• Liposomal nanomedicines

  2008cited by this paper
• Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN.

  2008cited by this paper
• The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel

  2008cited by this paper
• Lipid carriers: a versatile delivery vehicle for proteins and peptides.

  2008cited by this paper
• Docetaxel in the treatment of advanced non-small-cell lung cancer

  2008cited by this paper
• Paclitaxel and docetaxel in the treatment of breast cancer

  2008cited by this paper
• Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice.

  2007cited by this paper
• Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.

  2007cited by this paper
• Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis

  2007cited by this paper
• Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.

  2007cited by this paper
• A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells

  2006cited by this paper
• Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers.

  2006cited by this paper
• Preparation and characteristics of monostearin nanostructured lipid carriers.

  2006cited by this paper
• A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle System

  2006cited by this paper
• Preclinical experience with docetaxel in gastrointestinal cancers.

  2005cited by this paper
• Docetaxel for treatment of solid tumours: a systematic review of clinical data.

  2005cited by this paper
• Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells

  2005cited by this paper
• Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line.

  2004cited by this paper
• Study of suboptimum treatment response: lessons from breast cancer.

  2003cited by this paper
• Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel.

  2003cited by this paper
• Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.

  2002cited by this paper
• Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.

  2001cited by this paper
• Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

  2000cited by this paper
• The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review

  1999cited by this paper
• Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience.

  1995cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper

• Biotin-Directed Solid Lipid Nanoparticles for Targeted Delivery of Methotrexate in Biotin Receptor-Overexpressing Tumors

  2026cites this paper
• Nanostructured Lipid Carrier (NLCs): Next Generation Lipid Nanocarriers for Breast Cancer Therapy

  2026cites this paper
• Innovative Theranostics Strategies in the Fight Against Lung Cancer.

  2025cites this paper
• Delivery of Natural Small Molecules Through Nanocarriers for Cancer Treatment

  2025cites this paper
• Engineered monoclonal antibody nanoconjugates for specifically guided therapies against breast cancer

  2025cites this paper
• Formulation of repurposed celecoxib-loaded nanostructured lipid carriers using Box Behnken design, its characterization, and anticancer evaluation.

  2025cites this paper
• Quality by Design Optimization of Zolmitriptan Nanostructured Lipid Carriers for Nose-to-brain Delivery in Migraine

  2025cites this paper
• Docetaxel and quercetin-loaded lipid nanocarrier optimized by quality by design for glioblastoma therapy: a ligand-conjugated and therapeutic repurposing approach

  2025cites this paper
• Development, optimization, and characterization of docetaxel-loaded nanostructured lipid carriers for gastric cancer treatment

  2025cites this paper
• Design and in vitro cytotoxicity of docetaxel-loaded hyaluronic acid-coated nanostructured lipid carriers in breast cancer cells

  2025cites this paper
• Fabrication of folic acid-embedded aminated drug encapsulated zeolitic imidazolate framework as promising drug delivery system for lung cancer

  2024cites this paper
• Experimental Design Supported Formulation and Evaluation of Nanostructured Lipid Carrier Loaded Oro mucosal Film of Tenofovir Disoproxil Fumarate

  2024cites this paper
• A Comprehensive Review of Nanostructured Lipid Carriers: Innovations and Applications in Breast Cancer Treatment.

  2024cites this paper
• Construction of Sorafenib Tosylate and Etoposide‐loaded Liposomes: A Path to Precision Liver Cancer Therapy and its Apoptosis Induction

  2024cites this paper
• Antiproliferative activity of syringic acid-loaded nanostructured lipid carriers against MCF-7 human breast carcinoma cells.

  2024cites this paper
• Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting.

  2024cites this paper
• Leveraging nanostructured lipid carriers to enhance targeted delivery and efficacy in breast cancer therapy: a comprehensive review

  2024cites this paper
• Development and Evaluation of Docetaxel-Loaded Nanostructured Lipid Carriers for Skin Cancer Therapy

  2024influential citation
• Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy

  2024cites this paper
• Enhanced Antidiabetic Performance Through Optimized Charantin-Loaded Nanostructured Lipid Carriers: Formulation and In Vivo Studies in diabetic mice

  2024cites this paper
• A Critical Appraisal of Lipid Nanoparticles Deployed in Cancer Pharmacotherapy.

  2023cites this paper
• Nano-interventions for the Drug Delivery of Docetaxel to Cancer Cells

  2023cites this paper
• Nanostructured Lipid Carriers (NLCs) as Effective Drug Delivery Systems: Methods of Preparation and their Therapeutic Applications.

  2023cites this paper
• Nanomedicine in therapeutic warfront against estrogen receptor–positive breast cancer

  2023cites this paper
• Data-driven development of an oral lipid-based nanoparticle formulation of a hydrophobic drug

  2023cites this paper
• Progress in Programmable DNA-Aided Self-Assembly of the Master Frame of a Drug Delivery System.

  2023cites this paper
• Development and characterization of nanostructure lipid carrier for anti-hepatitis-C virus drug

  2023cites this paper
• Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer.

  2023cites this paper
• Review of the Role of Nanotechnology in Overcoming the Challenges Faced in Oral Cancer Diagnosis and Treatment

  2023cites this paper
• Nanodelivery systems for cutaneous melanoma treatment.

  2023cites this paper
• Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy

  2023cites this paper
• Overcoming biological barriers BBB/BBTB by designing PUFA functionalised lipid-based nanocarriers for glioblastoma targeted therapy.

  2023cites this paper
• Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review

  2023cites this paper
• Nanomedicine: A pragmatic approach for tackling melanoma skin cancer

  2023cites this paper
• Influence of Surface-Modification via PEGylation or Chitosanization of Lipidic Nanocarriers on In Vivo Pharmacokinetic/Pharmacodynamic Profiles of Apixaban

  2023cites this paper
• Nanocarrier Based Delivery of Berberine: A Critical Review on Pharmaceutical and Preclinical Characteristics of the Bioactive.

  2023cites this paper
• Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery

  2022cites this paper
• Docetaxel Loaded in Copaiba Oil-Nanostructured Lipid Carriers as a Promising DDS for Breast Cancer Treatment

  2022influential citation
• Current novel drug deliveries for oral cancer: A Chronotherapeutic approach.

  2022cites this paper
• Metabolic syndromes responsible for cervical cancer and advancement of nanocarriers for efficient targeted drug delivery- A review

  2022cites this paper
• Lung cancer targeting efficiency of Silibinin loaded Poly Caprolactone /Pluronic F68 Inhalable nanoparticles: In vitro and In vivo study

  2022cites this paper
• Development of trimethyl chitosan coated nanostructure lipid carriers to enhance the brain targeting capacity of ceftriaxone

  2022cites this paper
• Glioblastoma Multiforme Targeted Delivery Of Docetaxel Using Bevacizumab-Modified Nanostructured Lipid Carriers Impair In Vitro Cell Growth And In Vivo Tumor Progression.

  2022cites this paper
• Pectin coated Nanostructured Lipid Carriers for Targeted Piperine Delivery to Hepatocellular Carcinoma.

  2022cites this paper
• Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review.

  2022cites this paper
• Lipid based nanocarriers: Production techniques, concepts, and commercialization aspect

  2022cites this paper
• Advances in Lung Cancer Treatment Using Nanomedicines

  2022cites this paper
• Tailoring Apixaban in Nanostructured Lipid Carrier Enhancing Its Oral Bioavailability and Anticoagulant Activity

  2022cites this paper
• An Innovative Formulation Based on Nanostructured Lipid Carriers for Imatinib Delivery: Pre-Formulation, Cellular Uptake and Cytotoxicity Studies

  2022cites this paper
• Melanoma Management: From Epidemiology to Treatment and Latest Advances

  2022cites this paper
• Formulation and in-vitro evaluation of long circulating coated vitamin ETPGS phytosomes of docetaxel

  2022cites this paper
• A spotlight on alkaloid nanoformulations for the treatment of lung cancer

  2022cites this paper
• Synthesis and Potential Applications of Lipid Nanoparticles in Medicine

  2022cites this paper
• Design and Evaluation of Two-Step Biorelevant Dissolution Methods for Docetaxel Oral Formulations

  2022cites this paper
• In Vitro Evaluation of NLS-DTX Activity in Triple-Negative Breast Cancer

  2022cites this paper
• In vivo antitumor activity study of targeted chlorambucil-loaded nanolipid carrier for breast cancer

  2022cites this paper
• A kNGR Peptide-Tethered Lipid–Polymer Hybrid Nanocarrier-Based Synergistic Approach for Effective Tumor Therapy: Development, Characterization, Ex-Vivo, and In-Vivo Assessment

  2022cites this paper
• How to Treat Melanoma? The Current Status of Innovative Nanotechnological Strategies and the Role of Minimally Invasive Approaches like PTT and PDT

  2022cites this paper
• Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids?

  2021cites this paper
• PLA-based core-shell structure stereocomplexed nanoparticles with enhanced loading and release profile of paclitaxel.

  2021influential citation
• Docetaxel and Lidocaine Co-Loaded (NLC-in-Hydrogel) Hybrid System Designed for the Treatment of Melanoma

  2021cites this paper
• Tumor-targeted hyaluronic acid-mPEG modified nanostructured lipid carriers for cantharidin delivery: An in vivo and in vitro study.

  2021cites this paper
• Synergic fabrication of pembrolizumab loaded doxorubicin incorporating microbubbles delivery for ultrasound contrast agents mediated anti-proliferation and apoptosis

  2021influential citation
• Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application.

  2021cites this paper
• Olanzapine Loaded Nanostructured Lipid Carriers via High Shear Homogenization and Ultrasonication

  2021cites this paper
• Different Microfluidic Environments for In Vitro Testing of Lipid Nanoparticles against Osteosarcoma

  2021cites this paper
• The Effects of Solid and Liquid Lipids on the Physicochemical Properties of Nanostructured Lipid Carriers.

  2021cites this paper
• Exploring the therapeutic potential of nanostructured lipid carrier approaches to tackling the inherent lacuna of chemotherapeutics and herbal drugs against breast cancer

  2021cites this paper
• Characterisation and cytotoxicity assay of curcumin nanostructured lipid carrier on HeLa cells

  2021cites this paper
• Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice

  2021cites this paper
• NANO-STRUCTURED LIPID CARRIERS: A PROMISING STRATEGY AND CURRENT PROGRESS IN RHEUMATOID ARTHRITIS AND PAIN MANAGEMENT

  2020cites this paper
• Current Trends of Targeted Drug Delivery for Oral Cancer Therapy

  2020cites this paper
• The effect of radiolabeled nanostructured lipid carrier systems containing imatinib mesylate on NIH-3T3 and CRL-1739 cells

  2020influential citation
• Encapsulation of Ficus deltoidea Extract in Nanostructured Lipid Carrier for Anti-melanogenic Activity

  2020cites this paper
• Novel pH-triggered biocompatible polymeric micelles based on heparin–α-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer

  2020cites this paper
• Encapsulation of Docetaxel into Diblock Polymeric Polymersome as a Nanodrug

  2020cites this paper
• Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer

  2020cites this paper
• Phytonanomedicines as Topical Alternatives for the Treatment of Skin Cancer

  2020cites this paper
• Solid lipid nanoparticles and nanostructured lipid carriers in oral cancer drug delivery

  2020cites this paper
• Use of Nanoparticles in Medicine

  2020cites this paper
• Solid Lipid Nanoparticles

  2020cites this paper
• Nanostructured Lipid carrier: A Novel Approach to enhance Solubility, Bioavailability, Stability and Permeability of Drug.

  2020cites this paper
• Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review

  2020cites this paper
• Oral Squamous Cell Carcinoma and the Cutting Edge of Nanotechnology

  2020cites this paper
• Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement

  2020cites this paper
• Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells

  2020cites this paper
• Recent advances in solid lipid nanoparticles formulation and clinical applications

  2020cites this paper
• An Industrially Viable Technique for Fabrication of Docetaxel NLCs for Oncotherapy.

  2020cites this paper
• LIPID-BASED NANOSYSTEM AS INTELLIGENT CARRIERS FOR VERSATILE DRUG DELIVERY APPLICATIONS.

  2020cites this paper
• Toxicological profile of lipid-based nanostructures: are they considered as completely safe nanocarriers?

  2020cites this paper
• Synthesis and Investigation of the Curcumin-Loaded Magnetic Lipid Nanoparticles and Their Cytotoxicity Assessment on Human Breast Carcinoma Cell Line

  2020cites this paper
• Nanostructure Lipid Carrier (NLC)-An Overview

  2020cites this paper
• Nanocarriers in drug delivery system: Eminence and confront

  2020cites this paper
• Docetaxel Loaded Pomegranate Seed Oil Based Nanostructured Lipid Carriers: A Potential Alternative to Current Formulation

  2020cites this paper
• Tailoring functional nanostructured lipid carriers for glioblastoma treatment with enhanced permeability through in-vitro 3D BBB/BBTB models.

  2020cites this paper
• In Vitro and In Vivo Models for Cancer and Infectious Diseases

  2019cites this paper
• Recent Advances in Development of Nano Drug Delivery

  2019cites this paper
• Evaluation of a self-nanoemulsifying docetaxel delivery system.

  2019cites this paper
• Recent advances in lipid nanocarriers applicable in the fight against cancer

  2019cites this paper
• Pharmaceutical nanotechnology: Brief perspective on lipid drug delivery and its current scenario

  2019cites this paper